aplicação de insulina em diabéticos.1 . *NPL: Protamina Neutra Lispro; ** NPA: Protamina Neutra Aspart; ***NPH: Protamina Neutra Fonte: A atividade da insulina lispro inicia-se aproximadamente 15 minutos após a . médico e leve a embalagem ou bula do medicamento, se possível. Ligue para. subcutaneously administered insulin lispro 8 units from a study in 12 patients with type 1 diabetes is Subcutaneous Insulin Lispro in Type 1 Diabetes Patients*.

Author: Magar Vulkis
Country: Suriname
Language: English (Spanish)
Genre: Technology
Published (Last): 23 May 2016
Pages: 146
PDF File Size: 7.23 Mb
ePub File Size: 4.45 Mb
ISBN: 352-9-87921-724-2
Downloads: 35975
Price: Free* [*Free Regsitration Required]
Uploader: Moogudal

Ideal for people with no prescription coverage,or lispor is not covered Enter medicine name or company Start typing to retrieve search suggestions. Local allergy in patients is common.

Humalog should not be used if it appears cloudy, thickened, or slightly coloured or if solid particles are visible. Method of administration Humalog solution for injection should be given subcutaneously.


Skin and subcutaneous tissue disorders. Type I glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals.

The time course of insulin lispro action may vary in different individuals or at different times in the same individual and is dependent on dose, site of injection, blood supply, temperature and physical activity. The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by system organ insulkna and in order of decreasing incidence very common: If the combination is used, patients should be observed for signs and symptoms of heart failure, weight gain and oedema.


Hipoglicemiante – Wikipédia, a enciclopédia livre

This is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. Within muscle tissue this includes increasing glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake, while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid output.

Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.

Severe hypoglycaemia may lead to loss of consciousness, and in extreme cases, death. This should be kept in mind, if treatment with the combination of pioglitazone and Humalog is considered. Patients with diabetes should be advised to inform their doctor if they are pregnant or are contemplating pregnancy.

Includes Humalog side effects, interactions and indications. A10AB04 The primary activity of insulin lispro is the regulation of glucose metabolism. This medicinal product should not be mixed with any other bbula or any other medicinal product.

Time to maximum concentration was also similar between formulations. Insulin requirements and dosage adjustment Insulin requirements may be increased during illness or emotional disturbances. Insulin requirements usually fall during the first trimester and increase during the second and third trimesters. After injection, the site of injection should not be massaged.

Name of the medicinal product 2.

Hypoglycaemia is the most frequent adverse reaction of insulin lispro therapy that a patient with diabetes may suffer. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia [see Warnings and Precautions Summary of safety profile Hypoglycaemia is the most frequent adverse reaction of insulin lispro therapy that a patient with diabetes may suffer.


Find out more here.

Humalog 200 Units/ml KwikPen, solution for injection in pre-filled pen

No specific frequency for hypoglycaemia is presented, since hypoglycaemia is a result of both the insulin dose and other factors e. Correction bbula moderately severe hypoglycaemia can be accomplished by intramuscular or subcutaneous administration of glucagon, followed by oral carbohydrate when the patient recovers sufficiently.

Date of revision of the text. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.

Acute, one month and twelve month toxicology studies produced no significant toxicity findings. Needles are not included.

Strengths Available for Humalog |

Cases of oedema have been reported with insulin therapy, particularly if previous poor metabolic control is improved by intensified insulin therapy. Studies also demonstrate that the dissociation of binding to the insulin receptor of insulin lispro is equivalent to human insulin. After first use 28 days. Eli Lilly Nederland B.

Use of injection sites should be rotated so that the same site is not used more than approximately once a lisro.